These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 37753164)

  • 1. Interleukin-36 is vasculoprotective in both sexes despite sex-specific changes in the coronary microcirculation response to IR injury.
    El-Awaisi J; Mitchell JL; Ranasinghe A; Kalia N
    Front Cardiovasc Med; 2023; 10():1227499. PubMed ID: 37753164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting IL-36 improves age-related coronary microcirculatory dysfunction and attenuates myocardial ischemia/reperfusion injury in mice.
    El-Awaisi J; Kavanagh DP; Rink MR; Weston CJ; Drury NE; Kalia N
    JCI Insight; 2022 Mar; 7(5):. PubMed ID: 35113814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging the injured beating heart intravitally and the vasculoprotection afforded by haematopoietic stem cells.
    Kavanagh DPJ; Lokman AB; Neag G; Colley A; Kalia N
    Cardiovasc Res; 2019 Nov; 115(13):1918-1932. PubMed ID: 31062860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving vasculoprotective effects of MSCs in coronary microvessels - benefits of 3D culture, sub-populations and heparin.
    Bumroongthai K; Kavanagh DPJ; Genever P; Kalia N
    Front Immunol; 2023; 14():1257497. PubMed ID: 37954606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring coronary blood flow by laser speckle contrast imaging after myocardial ischaemia reperfusion injury in adult and aged mice.
    El-Awaisi J; Kavanagh DPJ; Kalia N
    Front Cardiovasc Med; 2024; 11():1358472. PubMed ID: 38410244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting PDE4B (Phosphodiesterase-4 Subtype B) for Cardioprotection in Acute Myocardial Infarction via Neutrophils and Microcirculation.
    Wan Q; Xu C; Zhu L; Zhang Y; Peng Z; Chen H; Rao H; Zhang E; Wang H; Chu F; Ning X; Yang X; Yuan J; Wu Y; Huang Y; Hu S; Liu DP; Wang M
    Circ Res; 2022 Aug; 131(5):442-455. PubMed ID: 35899614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
    Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
    Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
    du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
    Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracoronary delivery of DNAzymes targeting human EGR-1 reduces infarct size following myocardial ischaemia reperfusion.
    Bhindi R; Fahmy RG; McMahon AC; Khachigian LM; Lowe HC
    J Pathol; 2012 Jun; 227(2):157-64. PubMed ID: 22344601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
    Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
    Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-34-NF-κB signaling aggravates myocardial ischemic/reperfusion injury by facilitating macrophage recruitment and polarization.
    Zhuang L; Zong X; Yang Q; Fan Q; Tao R
    EBioMedicine; 2023 Sep; 95():104744. PubMed ID: 37556943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of the heart to ischaemia-reperfusion injury and exercise-induced cardioprotection are sex-dependent in the rat.
    Brown DA; Lynch JM; Armstrong CJ; Caruso NM; Ehlers LB; Johnson MS; Moore RL
    J Physiol; 2005 Apr; 564(Pt 2):619-30. PubMed ID: 15718263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A historical review of experimental imaging of the beating heart coronary microcirculation in vivo.
    Kalia N
    J Anat; 2023 Jan; 242(1):3-16. PubMed ID: 34905637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury.
    Cao Z; Hu Y; Wu W; Ha T; Kelley J; Deng C; Chen Q; Li C; Li J; Li Y
    Cardiovasc Res; 2009 Dec; 84(3):442-51. PubMed ID: 19586942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-33 induces type-2-cytokine phenotype but exacerbates cardiac remodeling post-myocardial infarction with eosinophil recruitment, worsened systolic dysfunction, and ventricular wall rupture.
    Ghali R; Habeichi NJ; Kaplan A; Tannous C; Abidi E; Bekdash A; Farhat R; Itani H; Jurjus A; Booz GW; Mallat Z; Zouein FA
    Clin Sci (Lond); 2020 Jun; 134(11):1191-1218. PubMed ID: 32432676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-37 ameliorates myocardial ischaemia/reperfusion injury in mice.
    Wu B; Meng K; Ji Q; Cheng M; Yu K; Zhao X; Tony H; Liu Y; Zhou Y; Chang C; Zhong Y; Zhu Z; Zhang W; Mao X; Zeng Q
    Clin Exp Immunol; 2014 Jun; 176(3):438-51. PubMed ID: 24527881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor antagonism attenuates platelet and neutrophil activation and reduces myocardial injury during coronary reperfusion.
    Ko W; Lang D; Hawes AS; Zelano JA; Isom OW; Krieger KH
    J Surg Res; 1993 Nov; 55(5):504-15. PubMed ID: 8231170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.
    Pachel C; Mathes D; Arias-Loza AP; Heitzmann W; Nordbeck P; Deppermann C; Lorenz V; Hofmann U; Nieswandt B; Frantz S
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):629-35. PubMed ID: 26916731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathelicidin aggravates myocardial ischemia/reperfusion injury via activating TLR4 signaling and P2X
    Wu Y; Zhang Y; Zhang J; Zhai T; Hu J; Luo H; Zhou H; Zhang Q; Zhou Z; Liu F
    J Mol Cell Cardiol; 2020 Feb; 139():75-86. PubMed ID: 31982429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.